Public health, innovation, intellectual property and trade

72nd WHA Technical Briefing on Local Production: Launch of Interagency Statement on Promoting Local Production

Six international organizations – The Global Fund, UNAIDS, UNCTAD, UNICEF, UNIDO and WHO – launched the first interagency statement on promoting local production at the 72nd World Health Assembly Technical Briefing on Local Production. The interagency statement signals the 6 organizations aiming to work in a strategic, holistic and collaborative manner in partnership with governments and other stakeholders in promoting sustainable local production of quality-assured medicines and other health technologies.

Training workshop on Key Enabling Factors for Successful Local Production and Supply of Quality-Assured Medicines

WHO, in collaboration with USP-PQM and AUDA-NEPAD, organized a training workshop from 17-19 December 2018 in Addis Ababa for African manufacturers. The workshop built manufacturers’ capacity to cultivate and leverage upon key enabling factors to strengthen quality local production and be sustainable.

Training workshop on Key Enabling Factors for Successful Local Production and Supply of Quality-Assured Medicines

Launch of the National Strategy and Plan of Action for Pharmaceutical Manufacturing Development in Ethiopia

The Government of Ethiopia, with support from WHO, developed, launched and implemented the National Strategy and Plan of Action for Pharmaceutical Manufacturing Development in Ethiopia (2015-2025) (NSPA-Pharma) to improve access to quality-assured, safe, efficacious and affordable medicines in Ethiopia. During its implementation, Ethiopia has registered successes in strengthening local production under the NSPA-Pharma, including the inauguration of two new manufacturing facilities and development of industrial parks dedicated to pharmaceutical manufacturing, such as the Kilinto Pharmaceutical Industrial Park.


Local production & technology transfer for access to quality medical products

Local production has been discussed in World Health Assemblies since the 1970s. The adoption of Resolution WHA61.21 for the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (GSPA-PHI) brought a renewed focus on local production and related technology transfer as a strategy to promote innovation, build capacity and improve access to quality-assured medical products. The Local Production Programme has since been supporting Member States in strengthening sustainable local production and technology transfer in a holistic and strategic manner in collaboration with governments, partners and other stakeholders.

Low- and middle-income countries (LMICs) are becoming increasingly interested in developing the local production of quality-assured medical products. LMICs view local production as a strategy to improve access to quality medical products, achieve universal health coverage, strengthen health security and reach the health-related targets and broader development goals of the SDGs.

Technology transfer is a broad concept encompassing education and training, direct investment, licensing, movement of people, supply of materials and equipment, and other elements. The Local Production Programme has conducted landscape analyses on technology transfer for the local production of medical products with support from the European Commission.

Contact

Local Production Programme
20 Avenue Appia – 1211 Geneva 27
Switzerland